Skip to main contentAI and Advanced
/
MUKKA · NSEMarket ticker unavailable · configure an authorised index feed
MU
NSE · Equity shares · Food Processing-1.91 · -6.06%
Mukka Proteins MUKKA
NSE:INR 29.59
BSE:INR 23.4
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
AI analysis and Advanced tools for MUKKA
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 31.5
Day rangeINR 29.26 — INR 31.31
52-week rangeINR 18.27 — INR 33.29
Volume13.55 L
Market cap702.9
P/ENot available
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)1,449.45
Net Income (INR Cr)52.06
EPS1.74
Research path: Interpret Mukka Proteins's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
MUKKAMukka Proteins1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 1,621.13 | 1,076.32 | 940.79 |
| Other Liabilities Total | 2.53 | 2.74 | 2.26 |
| Long Term Debt | 32.1 | 2.39 | 6.39 |
| Common Stock Total | 30 | 30 | 30 |
| Other Equity Total | 0 | 6.17 | 10.57 |
| Other Current Assets Total | 210 | 42.33 | 35.13 |
| Total Assets | 1,621.13 | 1,076.32 | 940.79 |
| Current Portof LT Debt/Capital Leases | 738.4 | 5.82 | 6.83 |
| Cash | 12.88 | 3.08 | 94.44 |
| Total Equity | 499.09 | 440.7 | 396.09 |
| Long Term Investments | 77.92 | 37.92 | 32.4 |
| Retained Earnings(Accumulated Deficit) | 469.09 | 227.19 | 182.63 |
| Total Common Shares Outstanding | 30 | 30 | 30 |
| Tangible Book Valueper Share Common Eq | 16.16 | 14.46 | 13.2 |
| Goodwill Net | 14.05 | 6.75 | Not available |
| Total Liabilities | 1,122.04 | 635.62 | 544.7 |
| Total Debt | 779.29 | 452.91 | 365.27 |
| Short Term Investments | 17.05 | Not available | Not available |
| Cashand Short Term Investments | 29.93 | 3.08 | 94.44 |
| Total Receivables Net | 192.35 | 229.59 | 230.24 |
| Deferred Income Tax | 0 | 2.53 | 2.42 |
| Accounts Receivable-Trade Net | 181.83 | 199.82 | 185.34 |
| Property/Plant/Equipment Total-Net | 208.74 | 94.42 | 83.5 |
| Minority Interest | 29.69 | 15.8 | 12.22 |
| Total Current Liabilities | 1,048.93 | 610.41 | 520.93 |
| Total Inventory | 856.55 | 649.59 | 456.17 |
| Accounts Payable | 240.57 | 141.8 | 136.21 |
| Other Currentliabilities Total | 69.96 | 16.79 | 7.36 |
| Total Long Term Debt | 40.89 | 4.14 | 6.88 |
| Intangibles Net | 0.35 | 0.07 | 0.08 |
| Other Long Term Assets Total | 0.37 | 1.75 | 1.88 |
| Note Receivable-Long Term | 30.86 | 9.69 | 6.4 |
| Total Current Assets | 1,288.83 | 925.72 | 816.52 |
| Capital Lease Obligations | 8.79 | 1.75 | 0.49 |
| Accumulated Depreciation Total | Not available | -72.78 | -58.94 |
| Accrued Expenses | Not available | 3.05 | 18.97 |
| Prepaid Expenses | Not available | 1.14 | 0.55 |
| Additional Paid-In Capital | Not available | 177.35 | 172.89 |
| Property/Plant/Equipment Total-Gross | Not available | 158.64 | 142.44 |
| Notes Payable/Short Term Debt | Not available | 442.95 | 351.56 |
Fundamentals
Valuation and ratios
Valuation
Price to Sale Ratio0.48
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk40.93
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Nestle India | INR 1,483 | 2.87 L | 80.4 | — |
| Britannia Industries | INR 5,498.7 | 1.32 L | 51.47 | — |
| Tata Consumer Products | INR 1,085.7 | 1.07 L | 67.4 | — |
| Godrej Industries | INR 1,357.45 | 45,725.84 | 34.92 | — |
| Patanjali Foods | INR 335.5 | 36,506.05 | 18.91 | — |
Shareholding
Ownership
- Promoter
- 73.33%
- FII
- 1.73%
- Other
- 24.94%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Mukka Proteins share price: How the stock is performing a week after listing - UpstoxMarket news · 16 Jul 2026, 12:30 pm
Mukka Proteins share price: How the stock is performing a week after listing Upstox
Mukka Proteins Ltd Shareholders Approve Warrant Issuance - WhalesbookMarket news · 14 Jul 2026, 2:41 pm
Mukka Proteins Ltd Shareholders Approve Warrant Issuance Whalesbook
Mukka Proteins shareholders approve ₹470 crore warrant issue - scanx.tradeMarket news · 14 Jul 2026, 12:30 pm
Mukka Proteins shareholders approve ₹470 crore warrant issue scanx.trade
Mukka Proteins grants Rs 9.10 Cr loan to subsidiary at 8% interest - scanx.tradeMarket news · 9 Jul 2026, 9:56 pm
Mukka Proteins grants Rs 9.10 Cr loan to subsidiary at 8% interest scanx.trade
Mukka Proteins Extends Rs 9.1 Crore Inter-Corporate Loan to Subsidiary - TipRanksMarket news · 9 Jul 2026, 8:28 pm
Mukka Proteins Extends Rs 9.1 Crore Inter-Corporate Loan to Subsidiary TipRanks
Mukka Proteins Ltd is Rated Sell - MarketsMojoMarket news · 9 Jul 2026, 12:37 pm
Mukka Proteins Ltd is Rated Sell MarketsMojo
Corporate actions
Events
- annual General MeetingPOM
- board MeetingsTo consider other business matters.
- board MeetingsAudited Results & Raising of funds
- board Meetings(Revised)
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- annual General MeetingAGM
- board MeetingsTo consider other business matters.
Rusaka Markets Community
Discussion and sentiment for Mukka Proteins
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Mukka Proteins Limited is an animal protein company, engaged in the production of fish meal, fish oil and fish soluble paste as well as developing alternative proteins such as Black Soldier Fly Insect meal in the animal food segment. Its products include fish meal, fish oil, fish soluble paste, insect meal, insect oil, insect compost and humic acid. It manufactures and supplies fish meal, fish oil and fish soluble paste which are an essential ingredient in the manufacturing of aqua feed (for fish and shrimp), poultry feed (for broiler and layer) and pet food (dog and cat food). Further, fish oil also finds its application in pharmaceutical products (additionally, Omega-3 pills and related products derived from fish oil are gaining importance as high nutrient and healthy dietary supplements), soap manufacturing, leather tanneries and paint industries. It has commercialized insect meal and insect oil (collectively Insect Protein) as an ingredient for aqua feed, animal feed and pet food.
Company facts
- Industry
- Food Processing
- Sector
- Food Processing
- NSE Code
- MUKKA
- BSE Code
- 544135
Questions
Stock FAQ
What is the symbol and ISIN of Mukka Proteins?
Mukka Proteins has the symbol MUKKA and ISIN - INE0CG401037.
What is the current price of Mukka Proteins?
Mukka Proteins is currently trading at INR 29.59.
What are the year high and year low of Mukka Proteins?
Mukka Proteins has a year high of INR 33.29 and a year low of INR 18.27.
What is the market capitalization of Mukka Proteins?
Mukka Proteins has a market capitalization of INR 702.90 crore.
What is the P/E ratio of Mukka Proteins?
Mukka Proteins has a P/E ratio of NA.
What is the dividend yield of Mukka Proteins?
Mukka Proteins has a dividend yield of NA.
How is the financial performance of Mukka Proteins based on revenue, net income, and EPS?
Mukka Proteins has revenue of INR 1,449.45 crore, net income of INR 52.06 crore, and EPS of NA.
What is the book value of Mukka Proteins?
Mukka Proteins has a book value of NA.
What is the debt-to-equity ratio of Mukka Proteins?
Mukka Proteins has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Mukka Proteins?
Mukka Proteins has a price-to-book ratio of NA and a price-to-sales ratio of 0.48.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.